Yperzeele, L. https://orcid.org/0000-0002-5503-5724
Shoamanesh, A.
Venugopalan, Y. V.
Chapman, S.
Mazya, M. V.
Charalambous, M.
Caso, V.
Hacke, W.
Bath, P. M.
Koltsov, I.
Article History
Received: 16 August 2022
Accepted: 17 October 2022
First Online: 5 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: WH reports non-significant honoraria for his role as member of Steering Committees of Angels (BI) and Cerenovus as well as minor honoraria for his work in several safety and adjudication committees, all not related to this manuscript. WH was involved in several of the positive trials reported here (ECASS 3, DESTINY II, ESCAPE, and other supporting trials), which may be considered a potential conflict of interest. PB reports no conflict of interest related to this manuscript. He has received grants from British Heart Foundation, National Institute of Health Research. Received honoraria from DiaMedica, Moleac and Phagenesis for Advisory Boards. The other authors declares that there is no conflict of interest.